✦ LIBER ✦

Phase II study of XR5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with advanced ovarian cancer*

✍ Scribed by Christian Dittrich; Veronique Dieras; Pierre Kerbrat; Cornelis Punt; Roberto Sorio; Francesco Caponigro; Xavier Paoletti; Christine de Balincourt; Denis Lacombe; Pierre Fumoleau

Book ID: 111551010
Publisher: Springer US
Year: 2003
Tongue: English
Weight: 65 KB
Volume: 21
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1025476813365

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of XR 5000 (DACA), an inh

Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer

✍ C Dittrich; B Coudert; L Paz-Ares; F Caponigro; M Salzberg; T Gamucci; X Paolett 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Phase II study of XR 5000, an inhibitor

Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancer

✍ F Caponigro; C Dittrich; J.B Sorensen; J.H.M Schellens; F Duffaud; L Paz Ares; D 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Phase I and pharmacokinetic study of XR1

Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1–5 of a 3-weekly cycle in patients with advanced solid tumours

✍ de Jonge, M J A; Kaye, S; Verweij, J; Brock, C; Reade, S; Scurr, M; van Doorn, L 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB

Extended phase II study of paclitaxel as

Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with platinum

✍ A. du Bois; H.J. Lück; K. Buser; H.G. Meerpohl; C. Sessa; U. Klaassen; H. Meden; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 693 KB

A Phase II trial of aprinocarsen, an ant

A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C α, administered as a 21-day infusion to patients with advanced ovarian carcinoma

✍ Ranjana Advani; Prema Peethambaram; Bert L. Lum; George A. Fisher; Lynn Hartmann 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract ## BACKGROUND It has been postulated that protein kinase C α (PKC‐α) plays a pivotal role in signal transduction in tumor cancer cells. Aprinocarsen, a 20‐base antisense oligonucleotide, has shown ability to inhibit PKC‐α protein expression and inhibit tumor growth in human xenograft m

136 Single centre phase II trial of pacl

136 Single centre phase II trial of paclitaxel (Taxol) administered as a 3 hour infusion in patients with advanced non small cell lung cancer (NSCLC)

✍ Ranson, M.; Anderson, H.; Jayson, G.; Thatcher, N. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 136 KB